(Q39676530)

13 September 2017

title

Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro (English)

1 reference

human umbilical cord mesenchymal stem cell

13 September 2017

1 reference

1 reference

1 reference

9

Wonil Oh

1 reference

13 September 2017

2

Dong Hyun Kim

1 reference

13 September 2017

8

Yoon Sun Yang

1 reference

13 September 2017

6

Hong Bae Jeon

1 reference

13 September 2017

10

Jong Wook Chang

1 reference

13 September 2017

3

Dal-Soo Kim

1 reference

13 September 2017

Ju-Yeon Kim

1

1 reference

13 September 2017

Ji Hyun Kim

series ordinal

4

1 reference

13 September 2017

Sang Young Jeong

series ordinal

5

1 reference

13 September 2017

Eun Hui Lee

series ordinal

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

24 July 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

584

1 reference

13 September 2017

issue

16

1 reference

13 September 2017

page(s)

3601-3608

1 reference

The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of Niemann-Pick type C mouse by modulation of neuroinflammatory condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Neural stem cells improve memory in an inducible mouse model of neuronal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Galectin-3 promotes neural cell adhesion and neurite growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Galectin-3 regulates T-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Expression of galectin-3 modulates T-cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Secretion of the galectin family of mammalian carbohydrate-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Control of Mac-2 surface expression on murine macrophage cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Molecular mechanisms of "detachment-induced apoptosis--Anoikis".

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Roles of db-cAMP, IBMX and RA in aspects of neural differentiation of cord blood derived mesenchymal-like stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

Application of human umbilical cord blood-derived mesenchymal stem cells in disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2010.07.028

10.1016/J.FEBSLET.2010.07.028

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference